These features are reminiscent of the findings reported recently in BP induced by dipeptidyl peptidase IV inhibitors (“gliptins”) used in the treatment of diabetes (20–22), although a causal link between gliptin intake and BP has not yet been established. The gene discussed is DPP4; the disease is diabetes mellitus.